Medicare GLP-1 Coverage at $50: Your Step-by-Step Guide

What Is the Medicare GLP-1 Bridge?

The Medicare GLP-1 Bridge is a temporary program run by CMS (Centers for Medicare & Medicaid Services). It covers GLP-1 medications prescribed for weight management — not diabetes.

If you already have type 2 diabetes, your Medicare Part D plan likely covers your GLP-1 under the standard benefit. The Bridge is specifically for weight management prescriptions.

Key details:

• Starts: July 1, 2026 (today)
• Ends: December 31, 2027
• Copay: $50/month flat fee
• Covered drugs: Wegovy (injection and tablets), Zepbound KwikPen, Foundayo
• Requirements: Medicare Part D enrollment + prior authorization

The Bridge runs outside your Part D benefit. The $50 copay does not count toward your deductible or out-of-pocket limit. Low-income subsidies do not apply to the Bridge copay.

Do I Qualify?

To qualify for the Medicare GLP-1 Bridge, you must meet all of these criteria:

1. You Have Medicare Part D

You must be enrolled in a Medicare Part D prescription drug plan or a Medicare Advantage plan with drug coverage (MA-PD).

If you have Original Medicare without Part D, you need to enroll in a standalone Part D plan first.

2. You Meet Clinical Criteria

Your doctor must confirm you meet one of these:

• BMI ≥35 (no other conditions required)
• BMI ≥30 with at least one weight-related condition:
  • High blood pressure
  • High cholesterol
  • Sleep apnea
  • Osteoarthritis
  • Fatty liver disease (NAFLD/NASH)
• BMI ≥27 with:
  • Prediabetes, OR
  • Established cardiovascular disease (prior heart attack, stroke, peripheral artery disease, or diagnosed coronary artery disease)

Your doctor will document this in your prior authorization.

3. Your GLP-1 Is for Weight Management, Not Diabetes

If you have type 2 diabetes and your doctor is prescribing a GLP-1 for blood sugar control, you do not need the Bridge. Your Part D plan already covers GLP-1s for diabetes.

The Bridge is for people who:

• Do not have type 2 diabetes, OR
• Have type 2 diabetes but are being prescribed a GLP-1 specifically for weight management at a weight-management dose

4. You Are Not on Medicaid

If you have both Medicare and Medicaid (dual eligible), the Bridge does not apply. Your Medicaid coverage may already cover GLP-1s for weight management — check with your state Medicaid office.

How to Get Your Prior Authorization: July 1 Checklist

The prior authorization process is straightforward, but your doctor's office does the work. Here's how to make it go smoothly.

Step 1: Schedule an Appointment

Call your primary care doctor or the provider who would prescribe your GLP-1. Tell them:

"I'd like to discuss starting a GLP-1 under the new Medicare Bridge program. I understand it requires a prior authorization. Can we schedule an appointment?"

Bring to your appointment:

• Your Medicare card (with your Part D plan name)
• Recent weight measurements if you have them
• List of current medications
• List of weight-related health conditions (high blood pressure, sleep apnea, etc.)

Step 2: Confirm You Meet Clinical Criteria

Your doctor will:

• Measure your height and weight to calculate BMI
• Review your medical history for qualifying conditions
• Discuss which GLP-1 is right for you (Wegovy, Zepbound, or Foundayo)
• Confirm the medication is being prescribed for weight management

If you meet criteria, your doctor will move forward with the prior authorization.

Step 3: Your Doctor Submits the Prior Authorization

Starting July 1, 2026, your doctor's office submits the prior authorization to CMS through a centralized processor.

What the prior authorization includes:

• Your Medicare number
• Your BMI
• Qualifying condition(s)
• Which GLP-1 is being prescribed
• Prescribing physician's information

Timeline: CMS is processing prior authorizations within 72 hours during the launch period. Most are approved within 1-2 business days if documentation is complete.

Your doctor's office will receive approval or a request for more information.

Step 4: Get Your Prescription

Once the prior authorization is approved, your doctor sends the prescription to your pharmacy of choice.

Important: Make sure your pharmacy knows this is a Medicare Bridge prescription. The claim must route through the Bridge processor, not your regular Part D plan.

When you pick up your first prescription, you should pay $50. If the pharmacy quotes a different amount, ask them to verify the claim was processed through the Medicare GLP-1 Bridge.

Step 5: Refill Monthly

You will pay $50 for each 28-day or 30-day supply. Set a reminder to refill on time — the Bridge does not allow early refills or 90-day supplies.

Real Medicare Costs: Before vs. After the Bridge

Here's what Medicare beneficiaries were paying before July 1, 2026, compared to what they pay now under the Bridge.

If you were using a manufacturer savings card:

Before the Bridge, some beneficiaries used manufacturer copay cards like the Wegovy Savings Card or Zepbound Savings Program. However, Medicare does not allow manufacturer copay cards. Many people were paying full out-of-pocket prices or using the cards off-label, which is not permitted.

The Bridge provides the first legal, compliant path to affordable GLP-1s for Medicare beneficiaries who do not have diabetes.

What Drugs Are Covered?

As of July 1, 2026, the Medicare GLP-1 Bridge covers three GLP-1 medications:

1. Wegovy (semaglutide)

Injection form:

• Weekly subcutaneous injection
• Doses: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg
• FDA-approved for chronic weight management

Tablet form (approved June 2026):

• Daily oral tablet
• Doses: 7 mg, 14 mg
• FDA-approved for chronic weight management
• Easier for people who don't want injections

2. Zepbound (tirzepatide) — KwikPen Only

KwikPen injection:

• Weekly subcutaneous injection
• Doses: 5 mg, 10 mg, 15 mg
• FDA-approved for chronic weight management

Not covered: Zepbound vials. The Bridge only covers the KwikPen autoinjector format.

3. Foundayo (orforglipron)

Daily oral tablet:

• Doses: 12 mg, 24 mg, 36 mg, 45 mg
• FDA-approved May 2026 for chronic weight management
• First oral GLP-1 approved for weight management

Not covered under the Bridge:

• Ozempic (approved only for type 2 diabetes, not weight management)
• Mounjaro (approved only for type 2 diabetes, not weight management)
• Saxenda (older GLP-1; most Part D plans already cover it at lower cost)
• Compounded semaglutide or tirzepatide

If your doctor prescribes one of the non-covered GLP-1s, you will pay your regular Part D copay or out-of-pocket cost.

Pharmacy Guidance: Where to Fill Your Prescription

Most major pharmacy chains participate in the Medicare GLP-1 Bridge. However, not every pharmacy is set up to process Bridge claims on day one.

Participating Pharmacies (Confirmed as of July 1, 2026)

Retail pharmacies:

• CVS Pharmacy
• Walgreens
• Walmart Pharmacy
• Costco Pharmacy
• Sam's Club Pharmacy
• Rite Aid
• Kroger Pharmacy
• Safeway/Albertsons Pharmacy

Mail-order pharmacies:

• CVS Caremark (mail order)
• Express Scripts (mail order)
• OptumRx (mail order)

Tips for a Smooth First Fill

Call ahead. Before your prior authorization is approved, call your preferred pharmacy and ask:

"Do you process Medicare GLP-1 Bridge claims? I have a prescription for [Wegovy/Zepbound/Foundayo] under the new Bridge program."

Bring your Medicare card. The pharmacy needs your Medicare number to route the claim to the Bridge processor.

Expect $50. If the pharmacy quotes more than $50, ask them to verify:

1. The prior authorization is approved and active
2. The claim is routing through the Medicare GLP-1 Bridge (not your regular Part D plan)
3. The NDC (drug code) matches a covered product

If there's a problem:

• Ask the pharmacy to contact the Bridge help desk: 1-800-MEDICARE (1-800-633-4227)
• Have your doctor's office confirm the prior authorization was approved
• Try a different participating pharmacy

CVS, Walgreens, or Costco?

All three are reliable options. Here's what to consider:

CVS:

• Most locations nationwide
• CVS Caremark is the processor for many Part D plans
• May have the smoothest claim routing if your Part D plan uses CVS Caremark

Walgreens:

• Also widely available
• Good option if CVS is not convenient

Costco:

• Requires Costco membership for pharmacy access in most states
• Known for lower out-of-pocket costs on other medications
• Bridge copay is still $50 regardless of pharmacy, but Costco is a good choice if you already shop there

Mail order: If you prefer mail-order delivery, ask your doctor to write a prescription for a 30-day supply at a time (the Bridge does not allow 90-day fills). CVS Caremark mail order is the most common option for Medicare Part D beneficiaries.

What Happens After 2027?

The Medicare GLP-1 Bridge is a temporary program. It ends December 31, 2027.

Why It's Temporary

The Bridge was created as a stopgap until the Medicare BALANCE Model launches. BALANCE is a broader restructuring of how Medicare covers weight management, including GLP-1s, medical nutrition therapy, and behavioral programs.

BALANCE was originally scheduled to launch January 1, 2028. However, CMS announced in May 2026 that BALANCE is delayed. The new launch date is uncertain — possibly late 2028 or 2029.

Because of the delay, the Bridge was extended from its original end date (December 31, 2026) to December 31, 2027.

What to Expect After the Bridge Ends

If BALANCE launches on time (late 2028 or 2029):

BALANCE will provide permanent Medicare coverage for GLP-1s prescribed for weight management. The copay structure is not yet finalized, but CMS has indicated it will be income-based and likely lower than $50/month for most beneficiaries.

If BALANCE is delayed further:

CMS may extend the Bridge again, or it may end without a replacement. In that case, Medicare beneficiaries would return to paying out-of-pocket for GLP-1s prescribed for weight management (unless they have type 2 diabetes).

What You Can Do Now

Plan ahead. If you start a GLP-1 under the Bridge, talk to your doctor about:

• How long you plan to stay on the medication
• What your options will be if the Bridge ends and BALANCE has not launched
• Whether transitioning to a lower dose or stopping the medication in late 2027 makes sense for your health goals

Watch for updates. CMS will announce any changes to the Bridge timeline or BALANCE launch by mid-2027. Check Medicare.gov or ask your doctor's office for updates.

Consider GLP-1 savings strategies. If you are not yet on a GLP-1, read our GLP-1 insurance coverage guide to understand all your options, including:

• Manufacturer patient assistance programs (if you do not have Medicare)
• Telehealth GLP-1 programs
• Self-pay pricing strategies

For seniors, also review our guide on GLP-1 safety for seniors, which covers muscle loss prevention, hydration, and monitoring considerations for adults over 65.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. Medicare coverage policies are subject to change. Copay amounts, drug coverage, and program timelines are accurate as of July 1, 2026, based on CMS announcements. Always verify current coverage details with your Medicare Part D plan, doctor's office, or 1-800-MEDICARE before making healthcare decisions.